Frontiers in Aging Neuroscience

Article	Citations
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease	226
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases	206
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature	141
Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia	133
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study	127
Cellular Senescence in Brain Aging	125
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia	121
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis	107
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects	106
The Impact of Disease Comorbidities in Alzheimer's Disease	102
Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia	95
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases	90
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019	90
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab	86
APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease	80
Astrocyte Senescence and Alzheimer’s Disease: A Review	79
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases	78
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey	77
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease	76
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?	76
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype	74
Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease	72
Astroglia and Tau: New Perspectives	69
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease	67
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease	64

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain	63
Alzheimer’s Disease: An Update and Insights Into Pathophysiology	62
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases	60
Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease	60
The Role of Resting-State Network Functional Connectivity in Cognitive Aging	60
Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort	60
Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management	59
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review	59
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases	56
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?	56
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough	54
Channelrhodopsin Excitation Contracts Brain Pericytes and Reduces Blood Flow in the Aging Mouse Brain in vivo	54
Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress	53
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke	52
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease	52
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review	50
Grip Strength and the Risk of Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Cohort Studies	50
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis	49
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury	49
Detection of Mild Cognitive Impairment Using Convolutional Neural Network: Temporal-Feature Maps of Functional Near-Infrared Spectroscopy	48
Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease	48
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the	48
Stem Cells of the Aging Brain	46
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine	45
Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction	45
Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study	45
Hearing Loss and Cognition: What We Know and Where We Need to Go	45
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease	44
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer’s Disease	44
Identifying Early Mild Cognitive Impairment by Multi-Modality MRI-Based Deep Learning	44
Role of the Extracellular Matrix in Alzheimer’s Disease	44
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration	43
COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study	43
Clinical and Genetic Aspects of CADASIL	43
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications	43
Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease	42
Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia	42
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target	42
A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration	42
Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson’s Disease	42
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)	41
Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study	41
Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin	41
Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology	40
ADVIAN: Alzheimer's Disease VGG-Inspired Attention Network Based on Convolutional Block Attention Module and Multiple Way Data Augmentation	39
Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech	39
Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?	39
Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson’s Disease	39
Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype	38
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease	38

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research	37
Characterization of Age-Related Differences in the Human Choroid Plexus Volume, Microstructural Integrity, and Blood Perfusion Using Multiparameter Magnetic Resonance Imaging	37
Early Detection and Prevention of Alzheimer’s Disease: Role of Oxidative Markers and Natural Antioxidants	37
Effects of Virtual Reality Intervention on Cognition and Motor Function in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis	37
Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson’s Disease Severity	37
Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action	37
The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment	37
Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease	36
Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention	36
Neuregulins in Neurodegenerative Diseases	36
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease	36
Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes	35
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease	35
Effectiveness of an Innovative Cognitive Treatment and Telerehabilitation on Subjects With Mild Cognitive Impairment: A Multicenter, Randomized, Active-Controlled Study	35
Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies	35
The Emerging Role of the Interplay Among Astrocytes, Microglia, and Neurons in the Hippocampus in Health and Disease	35
Predicting Alzheimer’s Disease Conversion From Mild Cognitive Impairment Using an Extreme Learning Machine-Based Grading Method With Multimodal Data	35
Secreted Chaperones in Neurodegeneration	35
Genistein Attenuates Acute Cerebral Ischemic Damage by Inhibiting the NLRP3 Inflammasome in Reproductively Senescent Mice	35
Being the Family Caregiver of a Patient With Dementia During the Coronavirus Disease 2019 Lockdown	35
The Mitochondrial Unfolded Protein Response: A Hinge Between Healthy and Pathological Aging	35
The Role of Protein Persulfidation in Brain Aging and Neurodegeneration	35
Characterization of EEG Data Revealing Relationships With Cognitive and Motor Symptoms in Parkinson's Disease: A Systematic Review	34
The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago	34
Brain Ischemia as a Prelude to Alzheimer's Disease	34
Dysfunction of the Glymphatic System Might Be Related to Iron Deposition in the Normal Aging Brain	34
Effectiveness and Safety of Acupuncture for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis	34
Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's Disease	34
Mitochondrial Behavior in Axon Degeneration and Regeneration	34
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis	34
Chasing Protection in Parkinson’s Disease: Does Exercise Reduce Risk and Progression?	34
Local Brain-Age: A U-Net Model	33
Neurogranin: A Potential Biomarker of Neurological and Mental Diseases	33
The Role of Microglia in Perioperative Neuroinflammation and Neurocognitive Disorders	33
Age-Related Changes in Pain Perception Are Associated With Altered Functional Connectivity During Resting State	33
Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study	33
Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease	33
Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model	33
Glymphatic Dysfunction in Patients With Ischemic Stroke	33
Dl-3-n-Butylphthalide Promotes Remyelination and Suppresses Inflammation by Regulating AMPK/SIRT1 and STAT3/NF-κB Signaling in Chronic Cerebral Hypoperfusion	33
Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders	33
Graph Theory Analysis Reveals Resting-State Compensatory Mechanisms in Healthy Aging and Prodromal Alzheimer’s Disease	32
COVID-19-Related Intracerebral Hemorrhage	32
Acoustic and Language Based Deep Learning Approaches for Alzheimer's Dementia Detection From Spontaneous Speech	32
Progress of RAGE Molecular Imaging in Alzheimer’s Disease	32
Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease	32
Anodal Transcranial Direct Current Stimulation Can Improve Spatial Learning and Memory and Attenuate Aβ42 Burden at the Early Stage of Alzheimer’s Disease in APP/PS1 Transgenic Mice	31
Resilience and Psychobiological Response to Stress in Older People: The Mediating Role of Coping Strategies	31
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines	31
Role of mTOR-Regulated Autophagy in Synaptic Plasticity Related Proteins Downregulation and the Reference Memory Deficits Induced by Anesthesia/Surgery in Aged Mice	31
Propionate and Alzheimer’s Disease	31
Functional MRI-Specific Alterations in Executive Control Network in Mild Cognitive Impairment: An ALE Meta-Analysis	31
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders	31
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States	30
Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases	30
Microstructural Alterations in Hippocampal Subfields Mediate Age-Related Memory Decline in Humans	30
Identification of Circular RNA hsa_Circ_0003391 in Peripheral Blood Is Potentially Associated With Alzheimer's Disease	30
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform	30
Prevalence and Associated Risk Factors of Cognitive Frailty: A Systematic Review and Meta-Analysis	30
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy	30
Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy	30
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum	30
Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer's Disease	30
Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease	30
Dual-Task Exercise to Improve Cognition and Functional Capacity of Healthy Older Adults	29
Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke	29
Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI Improves Cognitive and Memory Function in the Mouse Model of Alzheimer’s Disease	29
The Future of GDNF in Parkinson's Disease	29
Mitochondrial Dysfunction and Parkinson’s Disease—Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy	29
Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease	29
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H	28
Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer’s Diseases	28
Factors Associated With the Dilation of Perivascular Space in Healthy Elderly Subjects	28
Intracranial Atherosclerotic Plaque Characteristics and Burden Associated With Recurrent Acute Stroke: A 3D Quantitative Vessel Wall MRI Study	28
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation	28
Functional MRI-Specific Alterations in Salience Network in Mild Cognitive Impairment: An ALE Meta-Analysis	28
Corticomotor Plasticity Predicts Clinical Efficacy of Combined Neuromodulation and Cognitive Training in Alzheimer’s Disease	28
Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer’s Disease Image Data Classification	27
Lactulose and Melibiose Attenuate MPTP-Induced Parkinson’s Disease in Mice by Inhibition of Oxidative Stress, Reduction of Neuroinflammation and Up-Regulation of Autophagy	27
Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism	27

Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke	27
Transcranial Electric Current Stimulation During Associative Memory Encoding: Comparing tACS and tDCS Effects in Healthy Aging	27
The Complexity of Microglial Interactions With Innate and Adaptive Immune Cells in Alzheimer’s Disease	27
Dihydroartemisinin Ameliorates Learning and Memory in Alzheimer’s Disease Through Promoting Autophagosome-Lysosome Fusion and Autolysosomal Degradation for Aβ Clearance	27
Mitochondrial Homeostasis and Signaling in Parkinson’s Disease	27
Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease	27
Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis	27
Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer’s Disease and Stroke	27
The Emerging Role of Neuropeptides in Parkinson’s Disease	27
Alzheimer’s Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural	27
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models	26
Axonal Degeneration in AD: The Contribution of Aβ and Tau	26
Autonomic Nervous System and Cognitive Impairment in Older Patients: Evidence From Long-Term Heart Rate Variability in Real-Life Setting	26
Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis	26
Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease	26
Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage	26
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction	26
A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid	26
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases	26
Mean Apparent Propagator MRI Is Better Than Conventional Diffusion Tensor Imaging for the Evaluation of Parkinson’s Disease: A Prospective Pilot Study	26
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology	26
Aberrant Amplitude of Low-Frequency Fluctuations in Different Frequency Bands in Patients With Parkinson’s Disease	26
Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-stroke Cognitive Impairment During the Acute Phase in Chinese Minor Stroke Patients	25
The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis	25
Exercise-Induced Benefits for Alzheimer’s Disease by Stimulating Mitophagy and Improving Mitochondrial Function	25
Structural and Functional Hippocampal Changes in Subjective Cognitive Decline From the Community	25
Classification and Graphical Analysis of Alzheimer’s Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype	25
Age-Related Alterations in DTI Metrics in the Human Brain—Consequences for Age Correction	25
Hypoxia-Inducible Factor 1α and 2α Have Beneficial Effects in Remote Ischemic Preconditioning Against Stroke by Modulating Inflammatory Responses in Aged Rats	25
Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors	25
The Roles of Optogenetics and Technology in Neurobiology: A Review	25
Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity	25
Vascular Dementia and Underlying Sex Differences	25
A Large-Scale Open Motion Dataset (KFall) and Benchmark Algorithms for Detecting Pre-impact Fall of the Elderly Using Wearable Inertial Sensors	25
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease	25
Contributions of Hippocampal Volume to Cognition in Healthy Older Adults	25
Regular Tai Chi Practice Is Associated With Improved Memory as Well as Structural and Functional Alterations of the Hippocampus in the Elderly	25
Transneuronal Degeneration in the Brain During Glaucoma	24
Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease	24
The Potential of Ferroptosis-Targeting Therapies for Alzheimer’s Disease: From Mechanism to Transcriptomic Analysis	24
Predicting MCI to AD Conversation Using Integrated sMRI and rs-fMRI: Machine Learning and Graph Theory Approach	24
The Human Body as a Super Network: Digital Methods to Analyze the Propagation of Aging	24
The Influence of Demographics and Vascular Risk Factors on Glymphatic Function Measured by Diffusion Along Perivascular Space	24
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities	24
Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease	24
Resveratrol Modulates the Gut-Brain Axis: Focus on Glucagon-Like Peptide-1, 5-HT, and Gut Microbiota	24
Acupuncture for the Treatment of Alzheimer's Disease: An Overview of Systematic Reviews	24
Association Between Parkinson’s Disease and Melanoma: Putting the Pieces Together	24
COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study	24
Application of Evans Index in Normal Pressure Hydrocephalus Patients: A Mini Review	24
Stress Granules and Neurodegenerative Disorders: A Scoping Review	24
LncRNAs Stand as Potent Biomarkers and Therapeutic Targets for Stroke	24
Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node	24
Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer’s Disease	24
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival	23
A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks	23
Convergent Functional Changes of Default Mode Network in Mild Cognitive Impairment Using Activation Likelihood Estimation	23
Epigenetics in Alzheimer’s Disease	23
Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints	23
Memory and Learning Deficits Are Associated With Ca2+ Dyshomeostasis in Normal Aging	23
Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway	23
The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease	23
Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics Analysis	23
Extracellular Vesicles From 3xTg-AD Mouse and Alzheimer’s Disease Patient Astrocytes Impair Neuroglial and Vascular Components	23
The role of brain derived neurotrophic factor in central nervous system	23
Interplay Between Microglia and Alzheimer’s Disease—Focus on the Most Relevant Risks: APOE Genotype, Sex and Age	23
The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation	23
Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets	23
Brain NAD Is Associated With ATP Energy Production and Membrane Phospholipid Turnover in Humans	23
Altered Brain Function in Cerebral Small Vessel Disease Patients With Gait Disorders: A Resting-State Functional MRI Study	23
A New Rat Model of Chronic Cerebral Hypoperfusion Resulting in Early-Stage Vascular Cognitive Impairment	23
Impaired Topographical Organization of Functional Brain Networks in Parkinson’s Disease Patients With Freezing of Gait	23
Acupuncture-Related Therapies for Parkinson's Disease: A Meta-Analysis and Qualitative Review	22
Gray Matter Deterioration Pattern During Alzheimer's Disease Progression: A Regions-of-Interest Based Surface Morphometry Study	22
Functional Disorganization of Small-World Brain Networks in Patients With Ischemic Leukoaraiosis	22
Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis	22
Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice	22
Inflammation, Cognition, and White Matter in Older Adults: An Examination by Race	22
Ketogenic diet prevents chronic sleep deprivation-induced Alzheimer’s disease by inhibiting iron dyshomeostasis and promoting repair via Sirt1/Nrf2 pathway	22
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue	22
Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease	22
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)	22
AChRs Degeneration at NMJ in Aging-Associated Sarcopenia–A Systematic Review	22
Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods	22
Enriched Environment Attenuates Pyroptosis to Improve Functional Recovery After Cerebral Ischemia/Reperfusion Injury	22
Redox Post-translational Modifications of Protein Thiols in Brain Aging and Neurodegenerative Conditions—Focus on S-Nitrosation	22
Altered Cholesterol Homeostasis in Huntington’s Disease	22
Assessment of Alzheimer’s Disease Based on Texture Analysis of the Entorhinal Cortex	22
Exercise Attenuates Brain Aging by Rescuing Down-Regulated Wnt/β-Catenin Signaling in Aged Rats	21
Language Impairment in Alzheimer’s Disease—Robust and Explainable Evidence for AD-Related Deterioration of Spontaneous Speech Through Multilingual Machine Learning	21
Metabolomic and Lipidomic Profiling of Preoperative CSF in Elderly Hip Fracture Patients With Postoperative Delirium	21
The Influence of Aging, Hearing, and Tinnitus on the Morphology of Cortical Gray Matter, Amygdala, and Hippocampus	21
Gray Matter Atrophy in Amnestic Mild Cognitive Impairment: A Voxel-Based Meta-Analysis	21
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer’s Disease	21
A Shift in Tissue Stiffness During Hippocampal Maturation Correlates to the Pattern of Neurogenesis and Composition of the Extracellular Matrix	21